| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $630.6M | — | +11.0% |
| R&D Expense | $39.8M | — | -21.2% |
| SG&A Expense | $159.5M | — | +44.1% |
| Operating Income | $563.0M | — | +5.4% |
| Pre-tax Income | $468.3M | — | +8.0% |
| Income Tax | $0 | — | — |
| Net Income | $294.7M | — | +23.6% |
| EPS (Basic) | $0.67 | — | +21.8% |
| EPS (Diluted) | $0.67 | — | +21.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $586.4M | -5.2% | -46.1% |
| Current Assets | $1.43B | -6.7% | -22.6% |
| Total Assets | $19.82B | +1.0% | +12.5% |
| Current Liabilities | $535.7M | -15.8% | -54.7% |
| Long-term Debt | $8.96B | +0.1% | +17.6% |
| Total Liabilities | $9.88B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $718.2M | — | +20.5% |
| Investing Cash Flow | -$477.9M | — | -194.8% |
| Financing Cash Flow | -$272.7M | — | +71.0% |
| +26.3% |
| Stockholders' Equity | $9.94B | +2.3% | +1.5% |